BXA-30439-36411
3 vaccinations
2 coded responses
36 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 405 / KY
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-13
Registered in v-safe
-
2021-01-13
Dose 1 — Pfizer-BioNTech
- 2021-01-13
- 2021-01-15
- 2021-01-16
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-27
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-03
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint painsAdult check-in
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-12
- 2021-03-17
- 2021-05-05
- 2021-08-04
-
2021-11-04
Dose 3 — Pfizer-BioNTech
- 2021-11-04
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint painsAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · HeadacheAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2021-12-09
Survey response — day 35, dose 3MedDRA: Cough, Oropharyngeal pain, Paranasal sinus discomfort, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Cough, sore throat, congestion, pressure in sinusesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-16
- 2022-02-03
-
2022-05-07
Survey response — 6 months, dose 3MedDRA: Hypertension, Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Severe preeclampsia, post party hypertensionMedDRA releases: 2024-11 · check-in free text available
- 2022-11-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
Free text
Release 10 — day 35, dose 3
Symptoms: Cough, sore throat, congestion, pressure in sinuses
Release 11 — 6 months, dose 3
Symptoms: Severe preeclampsia, post party hypertension
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release